Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H18O3S |
Molecular Weight | 278.367 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=CC=C(C)C2=C(C=C(C)C2=C1)S(O)(=O)=O
InChI
InChIKey=VIZXMHCBZLGUET-UHFFFAOYSA-N
InChI=1S/C15H18O3S/c1-9(2)12-6-5-10(3)15-13(8-12)11(4)7-14(15)19(16,17)18/h5-9H,1-4H3,(H,16,17,18)
Molecular Formula | C15H18O3S |
Molecular Weight | 278.367 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/3030907Curator's Comment: description was created based on several sources, including
http://aksci.com/item_detail.php?cat=R239
http://www.ncbi.nlm.nih.gov/pubmed/15667596
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3030907
Curator's Comment: description was created based on several sources, including
http://aksci.com/item_detail.php?cat=R239
http://www.ncbi.nlm.nih.gov/pubmed/15667596
Sodium gualenate (Azunol ST Tablets) is a water-soluble derivative of azulene, a natural product which is an antiinflammatory component of chamomile of the family of Asteraceae. Sodium gualenate was originally studied as an antiulcer agent, is primary indicated in conditions like Duodenal ulcer, Gastric ulcer, Gastritis, but it is also clinically used as a therapeutic agent in the treatment of inflammation of the mouth and throat, for example, pharyngitis as well as other inflammatory diseases such as tonsillitis, stomatitis and conjunctivitis. Although the mechanism by which sodium azulene sulfonate inhibited the capsaicin-induced pharyngitis is not yet unraveled, antioxidative effect, but not inhibitory effect on cyclooxygenase pathway, might be involved.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Preventive effects of oren-gedoku-to on mucositis caused by anticancer agents in patients with acute leukemia]. | 2003 Sep |
|
The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments. | 2005 Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.120ty.net/bencandy.php?fid=273&id=34752
Put 1 tablet (5 mg of the active ingredient) between either of right or left upper lip and gum at a time, four times daily.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:56:28 GMT 2023
by
admin
on
Fri Dec 15 15:56:28 GMT 2023
|
Record UNII |
GR01836V0K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C80555
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY | |||
|
DTXSID10168665
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY | |||
|
GR01836V0K
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY | |||
|
2275
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY | |||
|
100000086674
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY | |||
|
SUB02421MIG
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY | |||
|
16915-32-5
Created by
admin on Fri Dec 15 15:56:28 GMT 2023 , Edited by admin on Fri Dec 15 15:56:28 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |